• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利那不勒斯“帕斯卡尔基金会”癌症中心(INT - IRCCS)在新冠疫情期间的临床与转化研究活动。

The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic.

作者信息

Buonaguro Franco M, Botti Gerardo, Ascierto Paolo Antonio, Pignata Sandro, Ionna Franco, Delrio Paolo, Petrillo Antonella, Cavalcanti Ernesta, Di Bonito Maurizio, Perdonà Sisto, De Laurentiis Michelino, Fiore Francesco, Palaia Raffaele, Izzo Francesco, D'Auria Stefania, Rossi Virginia, Menegozzo Simona, Piccirillo Mauro, Celentano Egidio, Cuomo Arturo, Normanno Nicola, Tornesello Maria Lina, Saviano Rocco, Barberio Daniela, Buonaguro Luigi, Giannoni Giovanni, Muto Paolo, Miscio Leonardo, Bianchi Attilio A M

机构信息

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.

出版信息

Infect Agent Cancer. 2020 Nov 23;15(1):69. doi: 10.1186/s13027-020-00330-7.

DOI:10.1186/s13027-020-00330-7
PMID:33292365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7681193/
Abstract

COVID-19 pandemic following the outbreak in China and Western Europe, where it finally lost the momentum, is now devastating North and South America. It has not been identified the reason and the molecular mechanisms of the two different patterns of the pulmonary host responses to the virus from a minimal disease in young subjects to a severe distress syndrome (ARDS) in older subjects, particularly those with previous chronic diseases (including diabetes) and cancer. The Management of the Istituto Nazionale Tumori - IRCCS "Fondazione Pascale" in Naples (INT-Pascale), along with all Health professionals decided not to interrupt the treatment of those hospitalized and to continue, even if after a careful triage in order not to allow SARS-CoV-2 positive subjects to access, to take care of cancer patients with serious conditions. Although very few (n = 3) patients developed a symptomatic COVID-19 and required the transfer to a COVID-19 area of the Institute, no patients died during the hospitalization and completed their oncology treatment. Besides monitoring of the patients, all employees of the Institute (physicians, nurses, researchers, lawyers, accountants, gatekeepers, guardians, janitors) have been tested for a possible exposure. Personnel identified as positive, has been promptly subjected to home quarantine and subdued to health surveillance. One severe case of respiratory distress has been reported in a positive employees and one death of a family member. Further steps to home monitoring of COVID-19 clinical course have been taken with the development of remote Wi-Fi connected digital devices for the detection of early signs of respiratory distress, including heart rate and oxygen saturation.In conclusion cancer care has been performed and continued safely also during COVID-19 pandemic and further remote home strategies are in progress to ensure the appropriate monitoring of cancer patients.

摘要

在中国和西欧爆发并最终失去势头的新冠疫情,如今正在肆虐南北美洲。尚未明确从年轻受试者的轻微疾病到老年受试者(尤其是那些患有既往慢性病(包括糖尿病)和癌症的患者)出现严重呼吸窘迫综合征(ARDS)的两种不同肺部宿主对病毒反应模式的原因及分子机制。那不勒斯的国家肿瘤研究所 - IRCCS“帕斯卡尔基金会”(INT - 帕斯卡尔)的管理层与所有医护人员决定不中断对住院患者的治疗,并继续(即使经过仔细分诊以防止新冠病毒阳性患者进入)照顾病情严重的癌症患者。尽管只有极少数(n = 3)患者出现有症状的新冠病毒感染并需要转至该研究所的新冠专区,但住院期间没有患者死亡,且他们完成了肿瘤治疗。除了对患者进行监测外,该研究所的所有员工(医生、护士、研究人员、律师、会计、门卫、监护人、勤杂工)都接受了可能暴露情况的检测。被确定为阳性的人员已被迅速进行居家隔离并接受健康监测。一名阳性员工报告出现了严重呼吸窘迫病例,一名家庭成员死亡。随着用于检测包括心率和血氧饱和度在内的呼吸窘迫早期迹象的远程Wi - Fi连接数字设备的开发,已采取了进一步的居家监测新冠临床病程的措施。总之,在新冠疫情期间也安全地开展并持续了癌症护理工作,并且正在推进进一步的远程居家策略以确保对癌症患者进行适当监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/b7ce6812f267/13027_2020_330_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/a0ba96b07fa3/13027_2020_330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/6dd26f44640b/13027_2020_330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/395eb52276ae/13027_2020_330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/8dd46bf2c75b/13027_2020_330_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/7210bcce2cd7/13027_2020_330_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/15ac09a14e59/13027_2020_330_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/464011fa83cd/13027_2020_330_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/6081b92c2f4b/13027_2020_330_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/a2a70772aca0/13027_2020_330_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/9bfd90cdb82d/13027_2020_330_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/b7ce6812f267/13027_2020_330_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/a0ba96b07fa3/13027_2020_330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/6dd26f44640b/13027_2020_330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/395eb52276ae/13027_2020_330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/8dd46bf2c75b/13027_2020_330_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/7210bcce2cd7/13027_2020_330_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/15ac09a14e59/13027_2020_330_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/464011fa83cd/13027_2020_330_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/6081b92c2f4b/13027_2020_330_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/a2a70772aca0/13027_2020_330_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/9bfd90cdb82d/13027_2020_330_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d6/7681992/b7ce6812f267/13027_2020_330_Fig11_HTML.jpg

相似文献

1
The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic.意大利那不勒斯“帕斯卡尔基金会”癌症中心(INT - IRCCS)在新冠疫情期间的临床与转化研究活动。
Infect Agent Cancer. 2020 Nov 23;15(1):69. doi: 10.1186/s13027-020-00330-7.
2
The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.那不勒斯IRCCS国家肿瘤研究所“G. 帕斯卡尔基金会”的肿瘤学临床试验组织及欧洲癌症研究与治疗组织(OECI)认证过程的影响。
Tumori. 2015;101 Suppl 1:S33-7. doi: 10.5301/tj.5000465. Epub 2015 Dec 30.
3
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“法斯卡莱基金会”癌症中心(INT - IRCCS)医护人员接种BNT162b2 mRNA抗SARS-CoV-2疫苗后抗体滴度呈双峰下降
Infect Agent Cancer. 2022 Jul 28;17(1):40. doi: 10.1186/s13027-022-00451-1.
4
Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“帕斯卡尔基金会”癌症中心(INT - IRCCS)医护人员的疫苗接种策略及抗SARS-CoV-2 S抗体滴度
Infect Agent Cancer. 2021 May 12;16(1):32. doi: 10.1186/s13027-021-00375-2.
5
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano.一家综合癌症中心对COVID-19大流行的应对:米兰IRCCS国家肿瘤研究所基金会的经验。
Tumori. 2020 May 4:300891620923790. doi: 10.1177/0300891620923790.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis.免疫疗法可能使癌症患者免受 SARS-CoV-2 感染:一项单中心回顾性分析。
J Transl Med. 2021 Mar 31;19(1):132. doi: 10.1186/s12967-021-02798-2.
8
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.PROTECT 试验:羟氯喹对比观察支持用于预防或 COVID-19 早期治疗的一项集群随机对照研究:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4.
9
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.预测转移性黑色素瘤患者免疫治疗临床获益的临床分类算法(CLICAL)和机器学习方法(SRF-CLICAL):来自意大利那不勒斯IRCCS帕斯卡基金会国家肿瘤研究所的真实世界证据
Cancers (Basel). 2021 Aug 19;13(16):4164. doi: 10.3390/cancers13164164.
10
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.

引用本文的文献

1
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review.2019冠状病毒病对肝细胞癌诊断和治疗的影响:一项系统综述
Explor Target Antitumor Ther. 2023;4(5):1039-1058. doi: 10.37349/etat.2023.00179. Epub 2023 Oct 26.
2
Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities.新冠疫情后肉瘤患者护理中的远程医疗:挑战与机遇
Cancers (Basel). 2023 Jul 21;15(14):3700. doi: 10.3390/cancers15143700.
3
mHealth in sub-Saharan Africa and Europe: A systematic review comparing the use and availability of mHealth approaches in sub-Saharan Africa and Europe.

本文引用的文献

1
Covid-19: Time for a paradigm change.新冠疫情:是时候进行范式转变了。
Rev Med Virol. 2020 Sep;30(5):e2134. doi: 10.1002/rmv.2134. Epub 2020 Jul 3.
2
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery.意大利在新冠疫情期间的观点:基于全国性调查,聚焦微创肝胰胆手术
Updates Surg. 2020 Jun;72(2):241-247. doi: 10.1007/s13304-020-00815-5. Epub 2020 May 29.
3
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.严重急性呼吸综合征冠状病毒2型的电子显微镜检查:一项具有挑战性的任务——作者回复
撒哈拉以南非洲和欧洲的移动健康:一项比较撒哈拉以南非洲和欧洲移动健康方法的使用情况及可得性的系统评价
Digit Health. 2023 Jun 21;9:20552076231180972. doi: 10.1177/20552076231180972. eCollection 2023 Jan-Dec.
4
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“法斯卡莱基金会”癌症中心(INT - IRCCS)医护人员接种BNT162b2 mRNA抗SARS-CoV-2疫苗后抗体滴度呈双峰下降
Infect Agent Cancer. 2022 Jul 28;17(1):40. doi: 10.1186/s13027-022-00451-1.
5
A SARS-CoV-2 Infection High-Uptake Program on Healthcare Workers and Cancer Patients of the National Cancer Institute of Naples, Italy.意大利那不勒斯国家癌症研究所针对医护人员和癌症患者的一项新冠病毒感染高接受度计划。
Healthcare (Basel). 2022 Jan 20;10(2):205. doi: 10.3390/healthcare10020205.
Lancet. 2020 May 30;395(10238):e100. doi: 10.1016/S0140-6736(20)31185-5. Epub 2020 May 19.
4
Colorectal surgery in Italy during the Covid19 outbreak: a survey from the iCral study group.新冠疫情期间意大利的结直肠手术:来自iCral研究小组的一项调查
Updates Surg. 2020 Jun;72(2):249-257. doi: 10.1007/s13304-020-00760-3. Epub 2020 May 20.
5
Comment on "Minimally Invasive Surgery and the Novel Coronavirus Outbreak: Lessons Learned in China and Italy".对《微创手术与新型冠状病毒爆发:中国和意大利的经验教训》的评论
Ann Surg. 2021 Dec 1;274(6):e765-e766. doi: 10.1097/SLA.0000000000003971.
6
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment.基于知识的抗丙型肝炎病毒直接抗病毒药物索磷布韦重新定位用于治疗严重急性呼吸综合征冠状病毒2。
Infect Agent Cancer. 2020 May 12;15:32. doi: 10.1186/s13027-020-00302-x. eCollection 2020.
7
SARS-CoV-2 RNA polymerase as target for antiviral therapy.SARS-CoV-2 RNA 聚合酶作为抗病毒治疗的靶点。
J Transl Med. 2020 May 5;18(1):185. doi: 10.1186/s12967-020-02355-3.
8
The need of COVID19 free hospitals to maintain cancer care.无新冠医院维持癌症治疗的必要性。
Eur J Surg Oncol. 2020 Jun;46(6):1186-1187. doi: 10.1016/j.ejso.2020.04.003. Epub 2020 Apr 22.
9
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.新冠疫情期间运营放射肿瘤学科室:意大利的经验
Adv Radiat Oncol. 2020 Mar 20;5(4):527-530. doi: 10.1016/j.adro.2020.03.003. eCollection 2020 Jul-Aug.
10
Anti-IL6R role in treatment of COVID-19-related ARDS.抗白细胞介素6受体在治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征中的作用
J Transl Med. 2020 Apr 14;18(1):165. doi: 10.1186/s12967-020-02333-9.